跳至主要内容
临床试验/ITMCTR2100004986
ITMCTR2100004986尚未招募1 期

Clinical observation of Wumei formula granules regulating Glu/GABA-Gln metabolic circuit and HPA axis in the treatment of insomnia in Jueyin syndrome

the Second Affiliated Hospital of Dalian Medical University0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 70(—)
性别
All

入选标准

  • 1. Aged 18-70 years old;
  • 2. Meet the diagnostic criteria of traditional Chinese medicine and the diagnostic criteria of western medicine for insomnia;
  • 3. Sign the informed consent and voluntarily join the clinical research observation;
  • 4. Be able to understand the research content and have normal communication and comprehension skills;
  • 5. Have not used related drugs for the treatment of insomnia, including traditional Chinese medicine, proprietary Chinese medicine and western medicine in the past 1 week.

排除标准

  • 1. Those who are allergic to umeboshi formula granules;
  • 2. Exclude organic brain diseases: such as Parkinson's, dementia, cerebrovascular disease, etc.: exclude insomnia caused by organic diseases: such as restless legs syndrome, periodic limb movements, OSAS, parasomnia, hypothyroidism, Hyperthyroidism, alcohol dependence, etc.
  • 3. There are obvious systemic pain, fever and infection and other diseases;
  • 4. Patients with insomnia due to obvious environmental interference or due to alcohol, coffee, drug dependence or mental disorders;
  • 5. Those who are currently taking drugs that affect sleep structure.

研究者

相似试验